Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vor Biopharma Inc. | Director | Stock Option (Right to Buy) | 30K | May 23, 2024 | Direct | ||
Dyne Therapeutics, Inc. | Director | Stock option (right to buy) | 25.1K | May 22, 2024 | Direct | ||
CARGO Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 23.7K | Jun 4, 2024 | Direct | ||
Arcellx, Inc. | Director | Stock Option (right to buy) | 8.01K | May 28, 2024 | Direct | ||
Gemini Therapeutics, Inc. /DE | Director | Stock Option (Right to Buy) | 0 | Oct 4, 2021 | Direct | ||
POINT Biopharma Global Inc. | Director | Common Stock | 0 | $12.45 | Dec 27, 2023 | Direct | |
POINT Biopharma Global Inc. | Director | Stock Option (Right to Buy) | 0 | Dec 27, 2023 | Direct |